Insmed, Inc. (INSM)
140.13
-3.44
(-2.40%)
USD |
NASDAQ |
Mar 06, 16:00
140.02
-0.11
(-0.08%)
After-Hours: 20:00
Insmed Cash from Investing (TTM) : -64.58M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 436.33M |
| Biogen, Inc. | -1.371B |
| Madrigal Pharmaceuticals, Inc. | 32.32M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Amicus Therapeutics, Inc. | -46.43M |